Basel, Switzerland

Hans Lengsfeld


Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 317(Granted Patents)


Location History:

  • Reinach, CH (1976 - 1993)
  • Basel, CH (1999 - 2011)

Company Filing History:


Years Active: 1976-2011

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovations of Hans Lengsfeld

Introduction

Hans Lengsfeld is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of obesity treatment. With a total of 14 patents to his name, Lengsfeld's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents is a composition that combines orlistat, a lipase inhibitor, with a bile acid sequestrant. This innovative pharmaceutical combination is designed to aid in the treatment of obesity. Another significant patent involves pharmaceutical compositions that include inhibitors of gastrointestinal and pancreatic lipases, such as orlistat, along with surfactants and dispersants. These inventions showcase his commitment to advancing healthcare solutions.

Career Highlights

Hans Lengsfeld is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to focus on developing effective treatments for obesity and related health issues. His expertise and dedication have positioned him as a key figure in his field.

Collaborations

Lengsfeld has collaborated with notable colleagues, including Paul Hadvary and Hans Steffen. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Hans Lengsfeld's contributions to pharmaceutical innovations, particularly in obesity treatment, highlight his role as a significant inventor in the industry. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…